Vitamin B12 Deficiency Testing: What Labs to Order and Why

Why B12 Deficiency Is So Commonly Missed

Vitamin B12 deficiency is estimated to affect 6% of adults under 60 and nearly 20% of adults over 60 — yet it is systematically underdiagnosed for two reasons.

First, the standard serum B12 reference range has a lower cutoff of approximately 200–250 pg/mL in most laboratories. This threshold was set to prevent overt megaloblastic anemia and subacute combined degeneration of the spinal cord. It does not protect against the neurological, cognitive, and metabolic impairments that begin at significantly higher levels — functional deficiency symptoms frequently appear below 400 pg/mL.

Second, the serum B12 test itself measures total cobalamin — including metabolically inactive analogues that inflate the apparent level without contributing to function. Methylmalonic acid (MMA) and homocysteine are superior functional markers.

Functions of Vitamin B12

B12 (cobalamin) functions as a cofactor in only two enzymatic reactions in humans — but these reactions are central to metabolism:

1. Methionine synthase: Converts homocysteine to methionine using a methyl group from 5-methyltetrahydrofolate (the active form of folate). This reaction simultaneously regenerates active folate for DNA synthesis and prevents homocysteine accumulation.

2. Methylmalonyl-CoA mutase: Converts methylmalonyl-CoA to succinyl-CoA in mitochondria — essential for odd-chain fatty acid metabolism and certain amino acid catabolism. B12 deficiency causes methylmalonyl-CoA to accumulate (elevated MMA), impairing myelin synthesis and neurological function.

The Neurological Presentation

B12 deficiency is unique among nutritional deficiencies in its tendency to present with neurological symptoms that can precede or occur without anemia:

Peripheral neuropathy: Symmetrical tingling, numbness, or burning in hands and feet — the earliest and most common neurological symptom.

Subacute combined degeneration: Damage to the posterior and lateral columns of the spinal cord, producing gait instability, weakness, and balance problems. Can be irreversible if untreated for more than 6–12 months.

Cognitive impairment: Memory problems, processing speed reduction, and dementia-like symptoms — particularly prevalent in older adults, frequently misattributed to aging.

Psychiatric manifestations: Depression, irritability, and psychosis in severe cases.

Superior Diagnostic Tests

Methylmalonic acid (MMA): Rises specifically when B12-dependent mitochondrial function is impaired. The most sensitive marker of functional B12 deficiency. Elevated MMA confirms deficiency even when serum B12 appears borderline normal.

Homocysteine: Rises when both B12 and folate are insufficient. Less specific than MMA (also elevated in folate deficiency, renal disease, and hypothyroidism) but clinically useful as a composite methylation marker.

Holotranscobalamin (active B12): Measures the metabolically active fraction of circulating B12. More sensitive than total B12 for early detection of depletion.

Optimal target for serum B12: Above 400–500 pg/mL. Above 600 pg/mL is advisable for older adults and those with neurological symptoms.

High-Risk Groups Requiring Proactive Testing

• Vegans and vegetarians (zero bioavailable B12 in plant foods)
• Adults over 60 — gastric acid declines with age, impairing B12 absorption from food
• Anyone taking metformin (reduces ileal absorption; risk is dose and duration dependent)
• Long-term proton pump inhibitor users (acid required for B12 release from food proteins)
• Those with pernicious anemia (autoimmune destruction of intrinsic factor, required for ileal B12 absorption)
• Individuals with gastric bypass or ileal resection

Supplementation

Form matters: Methylcobalamin is the directly active neurological form and requires no conversion. Cyanocobalamin (the most common supplement form) is cheaper but requires hepatic conversion and releases a small amount of cyanide during processing.

Dose: For those relying on oral supplementation alone, high doses (1,000–2,000 mcg daily) are necessary because passive absorption (approximately 1% of dose) bypasses the intrinsic factor-dependent active absorption pathway that fails in many deficient individuals.

Sublingual or intramuscular: For those with absorption disorders, sublingual B12 or intramuscular injections bypass gastrointestinal absorption entirely.